Related Experiment Videos
Comparative in vitro studies with 4-quinolone antimicrobials.
Drugs Under Experimental and Clinical Research
|January 1, 1985
Summary
Newer fluoroquinolones, including ciprofloxacin and ofloxacin, demonstrate superior antimicrobial activity compared to older drugs like nalidixic acid. These findings highlight the enhanced efficacy of modern 4-quinolones against clinical isolates.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Quinolones are a class of synthetic antibiotics widely used to treat bacterial infections.
- Nalidixic acid is the parent compound of the quinolone class, with newer derivatives showing improved properties.
Purpose of the Study:
- To determine the minimal inhibitory concentrations (MICs) of various 4-quinolone antibiotics against a range of clinical bacterial isolates.
- To compare the antimicrobial activity of newer 4-quinolones with older ones.
Main Methods:
- Agar dilution technique using Mueller-Hinton agar supplemented with lysed horse blood.
- Standardized inoculum of approximately 10(4) colony-forming units applied via multipoint inoculator.
- Determination of MIC, MIC50, and MIC90 for each antimicrobial and isolate.
Main Results:
- All newer 4-quinolones exhibited significantly greater antimicrobial activity than nalidixic acid, pipemidic acid, and cinoxacin.
- Ciprofloxacin and ofloxacin demonstrated the highest activity among the tested 4-quinolones.
- Varied MICs were observed across different clinical isolates, indicating differential susceptibility.
Conclusions:
- Modern 4-quinolones, particularly ciprofloxacin and ofloxacin, are more potent antimicrobial agents than their predecessors.
- These findings support the clinical utility of advanced fluoroquinolones in combating bacterial infections.